Patents by Inventor Sally A. Amundson

Sally A. Amundson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170283859
    Abstract: The disclosed subject matter provides a microdevice and techniques for single-cell gene expression profiling using a microfluidic device capable of cell-trapping, cell lysis, bead-based gene analysis. The microdevice can be capable of independent or parallelized, simultaneous quantitative genetic assays of single cells.
    Type: Application
    Filed: April 20, 2017
    Publication date: October 5, 2017
    Applicant: The Trustees Of Columbia University In the City of New York
    Inventors: Qiao Lin, Jing Zhu, Timothy R. Olsen, Hao Sun, Brian Ponnaiya, Sally A. Amundson, David J. Brenner
  • Patent number: 9255348
    Abstract: Exposure to ionizing radiation can produce a well-defined dose dependent signature in terms of changes in gene expression. In approaches and devices described herein, such a signature can be used to generate and use a self-contained radiation biodosimeter device, based on, for example, a blood finger stick. Various aspects of the invention are directed to biodosimetry with a fully integrated biochip using gene expression signatures.
    Type: Grant
    Filed: August 24, 2007
    Date of Patent: February 9, 2016
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Frederic Zenhausern, Christine Orozco, Mark Richards, Carl Yamashiro, Sally A. Amundson, Ralf Lenigk, Michael L. Bittner, Yoganand Balagurunathan
  • Publication number: 20100144558
    Abstract: Exposure to ionizing radiation can produce a well-defined dose dependent signature in terms of changes in gene expression. In approaches and devices described herein, such a signature can be used to generate and use a self-contained radiation biodosimeter device, based on, for example, a blood finger stick. Various aspects of the invention are directed to biodosimetry with a fully integrated biochip using gene expression signatures.
    Type: Application
    Filed: August 24, 2007
    Publication date: June 10, 2010
    Inventors: Frederic Zenhausern, Christine Orozco, Mark Richards, Carl Yamashiro, Sally A. Amundson, Ralf Lenigk, Michael L. Bittner, Yoganand Balagurunathan
  • Patent number: 7563573
    Abstract: A method is disclosed for detecting exposure of organisms to biologically significant or hazardous amounts of ionizing radiation. The method uses nucleic acid microarray hybridization to evaluate biological effects, such as patterns of expression of genes after radiation exposure. Numerous genes are provided which have been found to be responsive to radiation exposure in a variety of cell lines. These genes are incorporated into probe sets, which are exposed to a labeled nucleic acid composition from a test cell, such as cDNA reverse transcribed from mRNA in the test cell, which specifically hybridizes to members of the probe set when the cell has been exposed to a biologically significant amount of ionizing radiation. Whether the nucleic acid composition hybridizes to the nucleic acid molecules representing genes that are differentially expressed is determined.
    Type: Grant
    Filed: March 6, 2006
    Date of Patent: July 21, 2009
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Albert J. Fornace, Jr., Sally A. Amundson, Jeffrey M. Trent
  • Publication number: 20080176755
    Abstract: Exposure to ionizing radiation can produce a well-defined dose dependent signature in terms of changes in gene expression. In approaches and devices described herein, such a signature can be used to generate and use a self-contained radiation biodosimeter device, based on, for example, a blood finger stick. Various aspects of the invention are directed to biodosimetry with a fully integrated biochip using gene expression signatures.
    Type: Application
    Filed: August 24, 2007
    Publication date: July 24, 2008
    Applicant: The Trustees of Columbia University in the City of New York, Office of the General Counsel
    Inventors: Sally A. Amundson, Daniel Attinger, Chee Wei Wong
  • Publication number: 20070166726
    Abstract: A method is disclosed for detecting exposure of organisms to biologically significant or hazardous amounts of ionizing radiation. The method uses nucleic acid microarray hybridization to evaluate biological effects, such as patterns of expression of genes after radiation exposure. Numerous genes are provided which have been found to be responsive to radiation exposure in a variety of cell lines. These genes are incorporated into probe sets, which are exposed to a labeled nucleic acid composition from a test cell, such as cDNA reverse transcribed from mRNA in the test cell, which specifically hybridizes to members of the probe set when the cell has been exposed to a biologically significant amount of ionizing radiation. Whether the nucleic acid composition hybridizes to the nucleic acid molecules representing genes that are differentially expressed is determined.
    Type: Application
    Filed: March 6, 2006
    Publication date: July 19, 2007
    Inventors: Albert Fornace, Sally Amundson, Jeffrey Trent
  • Patent number: 7008768
    Abstract: A method is disclosed for detecting exposure of organisms to biologically significant or hazardous amounts of ionizing radiation. The method uses nucleic acid microarray hybridization to evaluate biological effects, such as patterns of expression of genes after radiation exposure. Numerous genes are provided which have been found to be responsive to radiation exposure in a variety of cell lines. These genes are incorporated into probe sets, which are exposed to a labeled nucleic acid composition from a test cell, such as cDNA reverse transcribed from mRNA in the test cell, which specifically hybridizes to members of the probe set when the cell has been exposed to a biologically significant amount of ionizing radiation. Whether the nucleic acid composition hybridizes to the nucleic acid molecules representing genes that are differentially expressed is determined.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: March 7, 2006
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Albert J. Fornace, Jr., Sally A. Amundson, Jeffrey M. Trent